646 related articles for article (PubMed ID: 24161909)
1. Japanese encephalitis: the virus and vaccines.
Yun SI; Lee YM
Hum Vaccin Immunother; 2014; 10(2):263-79. PubMed ID: 24161909
[TBL] [Abstract][Full Text] [Related]
2. Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Fischer M; Lindsey N; Staples JE; Hills S;
MMWR Recomm Rep; 2010 Mar; 59(RR-1):1-27. PubMed ID: 20224546
[TBL] [Abstract][Full Text] [Related]
3. Japanese encephalitis virus: Associated immune response and recent progress in vaccine development.
Kumar A; Sharma P; Shukla KK; Misra S; Nyati KK
Microb Pathog; 2019 Nov; 136():103678. PubMed ID: 31437579
[TBL] [Abstract][Full Text] [Related]
4. Development of a recombinant vaccine against Japanese encephalitis.
Kaur R; Vrati S
J Neurovirol; 2003 Aug; 9(4):421-31. PubMed ID: 12907387
[TBL] [Abstract][Full Text] [Related]
5. Protection of swine by potent neutralizing anti-Japanese encephalitis virus monoclonal antibodies derived from vaccination.
Young CL; Lyons AC; Hsu WW; Vanlandingham DL; Park SL; Bilyeu AN; Ayers VB; Hettenbach SM; Zelenka AM; Cool KR; Peterson GJ; Higgs S; Huang YS
Antiviral Res; 2020 Feb; 174():104675. PubMed ID: 31825852
[TBL] [Abstract][Full Text] [Related]
6. The current burden of Japanese encephalitis and the estimated impacts of vaccination: Combining estimates of the spatial distribution and transmission intensity of a zoonotic pathogen.
Moore SM
PLoS Negl Trop Dis; 2021 Oct; 15(10):e0009385. PubMed ID: 34644296
[TBL] [Abstract][Full Text] [Related]
7. Low Protective Efficacy of the Current Japanese Encephalitis Vaccine against the Emerging Genotype 5 Japanese Encephalitis Virus.
Cao L; Fu S; Gao X; Li M; Cui S; Li X; Cao Y; Lei W; Lu Z; He Y; Wang H; Yan J; Gao GF; Liang G
PLoS Negl Trop Dis; 2016 May; 10(5):e0004686. PubMed ID: 27139722
[TBL] [Abstract][Full Text] [Related]
8. Sero-Molecular Epidemiology of Japanese Encephalitis in Zhejiang, an Eastern Province of China.
Pan JR; Yan JY; Zhou JY; Tang XW; He HQ; Xie RH; Mao HY; Zhang YJ; Xie SY
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004936. PubMed ID: 27560360
[TBL] [Abstract][Full Text] [Related]
9. Product review on the JE vaccine IXIARO.
Firbas C; Jilma B
Hum Vaccin Immunother; 2015; 11(2):411-20. PubMed ID: 25621812
[TBL] [Abstract][Full Text] [Related]
10. Biological and genetic properties of SA₁₄-14-2, a live-attenuated Japanese encephalitis vaccine that is currently available for humans.
Song BH; Yun GN; Kim JK; Yun SI; Lee YM
J Microbiol; 2012 Aug; 50(4):698-706. PubMed ID: 22923123
[TBL] [Abstract][Full Text] [Related]
11. Partially neutralizing potency against emerging genotype I virus among children received formalin-inactivated Japanese encephalitis virus vaccine.
Fan YC; Chen JM; Chiu HC; Chen YY; Lin JW; Shih CC; Chen CM; Chang CC; Chang GJ; Chiou SS
PLoS Negl Trop Dis; 2012; 6(9):e1834. PubMed ID: 23029592
[TBL] [Abstract][Full Text] [Related]
12. Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease.
Hegde NR; Gore MM
Hum Vaccin Immunother; 2017 Jun; 13(6):1-18. PubMed ID: 28301270
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of live attenuated Japanese encephalitis SA 14-14-2 vaccine among Sri Lankan children with previous receipt of inactivated JE vaccine.
Wijesinghe PR; Abeysinghe MRN; Yoksan S; Yao Y; Zhou B; Zhang L; Fleming JA; Marfin AA; Victor JC
Vaccine; 2016 Nov; 34(48):5923-5928. PubMed ID: 27773472
[TBL] [Abstract][Full Text] [Related]
14. Clinical development of IMOJEV ®--a recombinant Japanese encephalitis chimeric vaccine (JE-CV).
Appaiahgari MB; Vrati S
Expert Opin Biol Ther; 2012 Sep; 12(9):1251-63. PubMed ID: 22775524
[TBL] [Abstract][Full Text] [Related]
15. Induction of cross-protection against two wild-type Taiwanese isolates of Japanese encephalitis virus using Beijing-1 strain DNA vaccine.
Wu CJ; Huang HW; Tao MH
Vaccine; 2003 Sep; 21(25-26):3938-45. PubMed ID: 12922129
[TBL] [Abstract][Full Text] [Related]
16. Electroporation enhances protective immune response of a DNA vaccine against Japanese encephalitis in mice and pigs.
Sheng Z; Gao N; Cui X; Fan D; Chen H; Wu N; Wei J; An J
Vaccine; 2016 Nov; 34(47):5751-5757. PubMed ID: 27743649
[TBL] [Abstract][Full Text] [Related]
17. Poly-γ-glutamic acid nanoparticles and aluminum adjuvant used as an adjuvant with a single dose of Japanese encephalitis virus-like particles provide effective protection from Japanese encephalitis virus.
Okamoto S; Yoshii H; Matsuura M; Kojima A; Ishikawa T; Akagi T; Akashi M; Takahashi M; Yamanishi K; Mori Y
Clin Vaccine Immunol; 2012 Jan; 19(1):17-22. PubMed ID: 22089248
[TBL] [Abstract][Full Text] [Related]
18. Mucosal vaccination approach against mosquito-borne Japanese encephalitis virus.
Harakuni T; Kohama H; Tadano M; Uechi G; Tsuji N; Matsumoto Y; Miyata T; Tsuboi T; Oku H; Arakawa T
Jpn J Infect Dis; 2009 Jan; 62(1):37-45. PubMed ID: 19168957
[TBL] [Abstract][Full Text] [Related]
19. Comparing the immunogenicity and safety of 3 Japanese encephalitis vaccines in Asia-Pacific area: A systematic review and meta-analysis.
Wang SY; Cheng XH; Li JX; Li XY; Zhu FC; Liu P
Hum Vaccin Immunother; 2015; 11(6):1418-25. PubMed ID: 25915588
[TBL] [Abstract][Full Text] [Related]
20. The immunogenicity of tetravalent dengue DNA vaccine in mice pre-exposed to Japanese encephalitis or Dengue virus antigens.
Prompetchara E; Ketloy C; Keelapang P; Sittisombut N; Ruxrungtham K
Asian Pac J Allergy Immunol; 2015 Sep; 33(3):182-8. PubMed ID: 26342114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
